Skip to main
NMTR
NMTR logo

NMTR Earnings Dates & Reports

NMTR Most Recent Earnings

Report DateMay 15, 2023
Period EndingQ1 2023
Est. EPS-$0.78
Actual EPS-$1.02
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

NMTR Earnings per Share (EPS) History

Signup for full access
Browse free

NMTR Latest Earnings

The value each NMTR share was expected to gain vs. the value each share gained.

NMTR reported its most recent earnings on May 15, 2023 for Q1 2023, posting earnings per share (EPS) of -$1.02. This exceeded analysts' expectations of -$0.78 by 30.77%, marking a Miss.

For comparison, 9 Meters Biopharma reported EPS of -$0.80 in the same quarter last year.

The company is expected to announce its next earnings report on 05/15/2023, with analysts projecting an EPS of $0.

NMTR Earnings History

Earnings
Est. EPSActual EPSSurprise
Q1 2023May 15, 2023
-$0.78-$1.02+30.77%
DeckReportListen
Q4 2022Mar 28, 2023
-$0.76-$0.92+21.05%
Q3 2022Nov 8, 2022
-$0.82-$0.72-12.20%
Q2 2022Aug 15, 2022
-$0.80-$0.800.00%
Q1 2022May 16, 2022
-$0.80
View all

NMTR Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the 9 Meters Biopharma’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Mar 28, 2023
Nov 8, 2022
Aug 15, 2022
May 16, 2022

NMTR Earnings FAQs

NMTR last reported earnings on May 15, 2023 for Q1 2023, posting an EPS of -$1.02, which Miss the estimate of -$0.78 by 30.77%.

For Q1 2023, NMTR reported an EPS of -$1.02, missing analysts' estimate of -$0.78 by 30.77%.

For Q1 2023, NMTR Miss expectations with an actual EPS of -$1.02 vs. an estimated EPS of -$0.78.

Following the last earnings report on May 15, 2023, NMTR's stock price moved — from — to —.

The next NMTR earnings call is scheduled for May. 15, 2023, where executives will discuss financial results and outlook.

9 Meters Biopharma (NMTR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.